The development of structured macroporous hydrogels are of great interest in many industries due to their high permeabilities, large surface areas and large pore volumes. In drug delivery and wound healing applications, these macropores may theoretically be utilized as large drug reservoirs to deliver anti-inflammatory drugs to a wound site, while simultaneously absorbing exudate and maintaining a hydrated environment in which the wound may heal. However, current methods of generating macroporous structured hydrogels are low-throughput, expensive, and require the use of organic solvents, salts, and other additives that are difficult to remove from the crosslinked hydrogel scaffold. In contrast, the Pressurized Gas eXpanded liquid (PGX) processing technology, patented by the University of Alberta and licensed for all industrial applications by Ceapro Inc., has been shown to generate purified and exfoliated biopolymer scaffolds in a less expensive and more efficient way.
Herein, the tunability of the PGX processing method was investigated in depth, varying solvent/anti-solvent ratios, nozzle mixing volume, polymer molecular weight, and polymer concentration to examine the resulting effects on produced polymer morphologies. PGX-processed chitosan and alginate scaffolds were stabilized as bulk hydrogels through post-processing crosslinking methods using anti-solvents, solid-state chemistries, and/or rapid gelation kinetics. The mechanical strength, swelling/degradation kinetics, affinity for protein uptake, and cytotoxicity of these stabilized scaffolds were subsequently examined and compared to hydrogels produced without the use of PGX processing. Furthermore, in situ crosslinking methods were explored, in which alginate and poly(oligoethylene glycol methacrylate) polymers were shown to form stable aerogels during the standard PGX processing method. Finally, the PGX apparatus was reconfigured to enable the impregnation of a model hydrophobic drug into pre-processed polymer scaffolds via circulation of supercritical CO2. The total loading was calculated and the release kinetics from loaded-scaffolds examined.
In conclusion, this work outlines a novel method of creating structured macroporous hydrogels from PGX processed biopolymers with the potential to provide improved drug loadings and sustained release profiles. It is expected that this work will provide a basis for a great deal of research into the further stabilization of scaffolds for use in other applications, the investigation of a larger range of bioactive molecules for impregnation and release, and the exploration of PGX hydrogel scaffolds for in vivo wound healing. / Thesis / Master of Applied Science (MASc)
| Identifer | oai:union.ndltd.org:mcmaster.ca/oai:macsphere.mcmaster.ca:11375/23739 |
| Date | January 2018 |
| Creators | Johnson, Kelli-anne |
| Contributors | Hoare, Todd, Chemical Engineering |
| Source Sets | McMaster University |
| Language | English |
| Detected Language | English |
| Type | Thesis |
Page generated in 0.0022 seconds